Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer Gayathri NagarajCynthia Ma Review 12 March 2015 Pages: 231 - 242
BI-RADS update for breast cancer caregivers Emily L. SedgwickLilian EbuomaKarla A. Sepulveda Review 12 March 2015 Pages: 243 - 254
Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1 Kaoru FujisakiHiroshi FujimotoMasaru Miyazaki Preclinical study 27 February 2015 Pages: 255 - 263
Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement Surojeet SenguptaMichael C. BiarnesV. Craig Jordan Preclinical Study 27 February 2015 Pages: 265 - 278
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial Ramona ErberOleg GluzArndt Hartmann Preclinical Study 28 February 2015 Pages: 279 - 288
Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic Lise B. AhlbornMette DandanellThomas v. O. Hansen Preclinical study Open access 28 February 2015 Pages: 289 - 298
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients Chiya OshiroNaofumi KagaraShinzaburo Noguchi Preclinical Study 04 March 2015 Pages: 299 - 307
The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells Wei Bin FangMin YaoNikki Cheng Preclinical Study 06 March 2015 Pages: 309 - 320
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer Callie R. MerrySarah McMahonAhmad M. Khalil Preclinical Study 08 March 2015 Pages: 321 - 334
Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer Rezvan AbduljabbarOla H. NegmIan O. Ellis Preclinical study 12 March 2015 Pages: 335 - 346
Pnck overexpression in HER-2 gene-amplified breast cancer causes Trastuzumab resistance through a paradoxical PTEN-mediated process Tushar B. DebAnnie H. ZuoMichael D. Johnson Preclinical Study 15 March 2015 Pages: 347 - 361
High tumor budding stratifies breast cancer with metastatic properties Bodour SalhiaMafalda TrippelCoya Tapia Preclinical study Open access 17 March 2015 Pages: 363 - 371
A nomogram based on mammary ductoscopic indicators for evaluating the risk of breast cancer in intraductal neoplasms with nipple discharge Zhen-Qiang LianQi WangSi-Mei Xie Clinical trial 07 March 2015 Pages: 373 - 380
The impact of breast cancer-related lymphedema on the ability to perform upper extremity activities of daily living Jean A. O’TooleChantal M. FergusonAlphonse G. Taghian Clinical Trial 07 March 2015 Pages: 381 - 388
The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer C. Villarreal-GarzaJ. N. WeitzelS. A. Narod Epidemiology 26 February 2015 Pages: 389 - 394
Smoking and survival in female breast cancer patients Alicia Padron-MonederoStacey L. TannenbaumMargaret M. Byrne Epidemiology 28 February 2015 Pages: 395 - 403
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies Alessandra GennariMauro CostaPaolo Bruzzi Epidemiology 06 March 2015 Pages: 405 - 413
A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort Laureen DartoisÉmilien GauthierGuy Fagherazzi Epidemiology 06 March 2015 Pages: 415 - 426
The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes Pauline A. J. VissersChris R. CardwellLiam J. Murray Epidemiology 12 March 2015 Pages: 427 - 437
Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis Jieqiong LiuWen JiangLisa K. Jacobs Epidemiology 13 March 2015 Pages: 439 - 445
Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast Huang-Chun LienYu-Ling ChenYung-Ming Jeng Epidemiology 14 March 2015 Pages: 447 - 455
Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients Jonine D. FigueroaHoward YangMaxwell Lee Epidemiology 15 March 2015 Pages: 457 - 466
